Key facts
- This page summarizes Ospraie Ag Science LLC's Form 4 filing for MARRONE BIO INNOVATIONS INC.
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 15 Jul 2022, 09:09.
Ospraie Ag Science LLC - 12 Jul 2022 Form 4 Insider Report for MARRONE BIO INNOVATIONS INC
- Reporting relationship
- Director, Other*, 10%+ Owner
- Issuer ticker
- N/A
- Reported as of
- 12 Jul 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 15 Jul 2022, 09:09:02 UTC
- Prior SEC filing
- 17 Dec 2021
- Source filing
- View source filing
- Reporting owner signature
- OSPRAIE AG SCIENCE LLC By: OAS MM, LLC, its managing member Name: /s/ Dwight Anderson Title: Managing Member
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Ospraie Ag Science LLC filed Form 4 for MARRONE BIO INNOVATIONS INC on 15 Jul 2022.
Change
- Previous filing in this sequence was filed on 17 Dec 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MBII
transaction
Common Stock, $0.00001 par value
Disposition pursuant to a tender of shares in a change of control transaction
- Transaction value
- Shares
- -70,836,258
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 12 Jul 2022
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Ospraie Ag Science LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 2 footnotes
Footnote F1
Disposed of pursuant to the Agreement and Plan of Merger dated March 16, 2022 by and among the Issuer, Bioceres Crop Solutions Corp. and BCS Merger Sub, Inc. (the "Merger Agreement") in exchange for 6,233,590 ordinary shares of Bioceres Crop Solutions Corp. having a market value of $9.44 per share at closing on the effective date of the merger.
Footnote F2
Ospraie Management, LLC ("Ospraie Management") is the investment manager of Ospraie Ag Science LLC ("Ospraie LLC") and has been delegated voting and investment power and thus beneficial ownership of the shares of Common Stock of the Issuer held by Ospraie LLC. Ospraie Holding I, LP ("Ospraie Holding") may be deemed to beneficially own the shares of Common Stock of the Issuer held by Ospraie LLC as the managing member of Ospraie Management. Ospraie Management, Inc. ("Ospraie Inc.") may be deemed to beneficially own the shares of Common Stock of the Issuer held by Ospraie LLC as the general partner of Ospraie Holding. OAS MM, LLC may be deemed to beneficially own the shares of Common Stock of the Issuer held by Ospraie LLC as the managing member of Ospraie LLC. Dwight Anderson may be deemed to beneficially own the shares of Common Stock of the Issuer held by Ospraie LLC as the Managing Principal of Ospraie Management, the sole owner of Ospraie Inc. and sole managing member of OAS MM, LLC. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, if any.
SEC remarks
Each of Ospraie Ag Science LLC, Ospraie Management, LLC, Ospraie Holding I, LP, Ospraie Management, Inc., OAS MM, LLC and Dwight Anderson (collectively, the "Reporting Persons") may be deemed a director by deputization of Marrone Bio Innovations, Inc. (the "Issuer") by virtue of the fact that Messrs. Robert A. Woods, Yogesh Mago, Keith McGovern and Stuart Woolf, representatives of the Reporting Persons, served on the board of directors of the Issuer prior to the closing of the merger contemplated by the Merger Agreement.